BTZ-043 - Multiple Ascending Dose (MAD) to Evaluate Safety, Tolerability and Early Bactericidal Activity (EBA)

Clinical trial NCT04044001 · COMPLETED

Trial details

NCT number: NCT04044001
Sponsor: Michael Hoelscher
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Pulmonary Tuberculoses Other Specified Pulmonary Tuberculosis

Start date: 2019-11-15
Primary completion: 2022-03-03
Enrollment: 77

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.